Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,754 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination Assay of Methylated HOXA1 with Tumor Markers Shows High Sensitivity for Detection of Early-Stage Hepatocellular Carcinoma.
Kunimune Y, Suehiro Y, Saeki I, Yamauchi Y, Tanabe N, Matsumoto T, Higaki S, Fujii I, Suzuki C, Okayama N, Nishioka M, Ichihara K, Nagano H, Sakaida I, Takami T, Yamasaki T. Kunimune Y, et al. Among authors: yamasaki t. Liver Cancer. 2024 Feb 14;13(5):487-497. doi: 10.1159/000536211. eCollection 2024 Oct. Liver Cancer. 2024. PMID: 39435267 Free PMC article.
Regulation of human GnT-IV family activity by the lectin domain.
Osada N, Nagae M, Yamasaki T, Harduin-Lepers A, Kizuka Y. Osada N, et al. Among authors: yamasaki t. Carbohydr Res. 2024 Oct 2;545:109285. doi: 10.1016/j.carres.2024.109285. Online ahead of print. Carbohydr Res. 2024. PMID: 39369636
Corrigendum to "Anti-tumor effect of antibody-drug conjugate targeting cell adhesion molecule 1 on GIST cells representing small intestinal GIST" [Experimental and Molecular Pathology 139 (2024) 104922].
Yoshida M, Yuan J, Kihara T, Kimura N, Yamasaki T, Ohkouchi M, Hashikura Y, Isozaki K, Hagiyama M, Ito A, Hirota S. Yoshida M, et al. Among authors: yamasaki t. Exp Mol Pathol. 2024 Sep 24:104934. doi: 10.1016/j.yexmp.2024.104934. Online ahead of print. Exp Mol Pathol. 2024. PMID: 39322523 Free article. No abstract available.
Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy.
Saeki I, Shimose S, Tomonari T, Ito T, Tani J, Takeuchi Y, Yoshioka N, Naito T, Takeuchi M, Kakizaki S, Hatanaka T, Sasaki K, Yasunaka T, Sakata M, Iwamoto H, Itano S, Shirono T, Tanabe N, Yamamoto T, Kanayama Y, Naganuma A, Nishina S, Otsuka M, Kobara H, Kawashima H, Takayama T, Kawaguchi T, Yamasaki T, Takami T; Hepatology InVestigator Experts in Japan (HIVE-J) Study Group. Saeki I, et al. Among authors: yamasaki t. PLoS One. 2024 Sep 25;19(9):e0311084. doi: 10.1371/journal.pone.0311084. eCollection 2024. PLoS One. 2024. PMID: 39321197 Free PMC article.
Real-world assessment of comprehensive genome profiling impact on clinical outcomes: A single-institution study in Japan.
Kunimasa K, Sugimoto N, Yamasaki T, Kukita Y, Fujisawa F, Inoue T, Yamaguchi Y, Kitasaka M, Sakai D, Honma K, Wakamatsu T, Yamamoto S, Hayashi T, Mabuchi S, Okuno J, Kawamura T, Kai Y, Urabe M, Nishimura K. Kunimasa K, et al. Among authors: yamasaki t. Cancer Med. 2024 Sep;13(18):e70249. doi: 10.1002/cam4.70249. Cancer Med. 2024. PMID: 39315676 Free PMC article.
Dose compliance of estramustine phosphate in neoadjuvant chemohormonal therapy combined with degarelix acetate predicts the biochemical recurrence in patients with very high-risk prostate cancer who underwent robot-assisted radical prostatectomy.
Kambe T, Yamasaki T, Yamamoto A, Nagoshi A, Fujiwara T, Mine Y, Hagimoto H, Igarashi A, Kokubun H, Murata S, Akagi N, Hattori Y, Abe Y, Tsutsumi N, Shibasaki N, Kawakita M. Kambe T, et al. Among authors: yamasaki t. Int J Urol. 2024 Sep 10. doi: 10.1111/iju.15579. Online ahead of print. Int J Urol. 2024. PMID: 39253858
1,754 results